Clinical Trial Update: Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCC [NA]

View source ↗

Summary

A clinical trial compares immediate versus deferred cytoreductive nephrectomy in metastatic renal cell carcinoma using ipilimumab and nivolumab; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Metastatic Renal Cell Carcinoma ( mRCC) | NA | Status: NOT_YET_RECRUITING